Retour
Fourchette du Jour
8,22 €
8,22 €
Fourchette 52 Semaines
6,60 €
14,80 €
Volume
100
Moyenne 50J / 200J
10,28 €
/
11,44 €
Clôture Précédente
8,22 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 34,2 | 0,4 |
| P/B | 3,1 | 2,9 |
| ROE % | 8,7 | 3,8 |
| Net Margin % | 47,1 | 3,9 |
| Rev Growth 5Y % | 112,0 | 10,0 |
| D/E | 0,0 | 0,2 |
Points Clés
Revenue grew 112,02% annually over 5 years — strong growth
Earnings declined -78,58% over the past year
Net margin of 47,09% shows strong profitability
Debt/Equity of 0,00 — conservative balance sheet
Generating 125,34M in free cash flow
P/E of 34,22 — premium valuation
Croissance
Revenue Growth (5Y)
112,02%
Revenue (1Y)-70,20%
Earnings (1Y)-78,58%
FCF Growth (3Y)-17,66%
Qualité
Return on Equity
8,67%
ROIC4,88%
Net Margin47,09%
Op. Margin34,07%
Sécurité
Debt / Equity
0,00
Current Ratio76,60
Interest Coverage0,00
Valorisation
P/E Ratio
34,22
P/B Ratio3,08
EV/EBITDA47,09
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -70,20% | Revenue Growth (3Y) | -47,22% |
| Earnings Growth (1Y) | -78,58% | Earnings Growth (3Y) | -55,99% |
| Revenue Growth (5Y) | 112,02% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 64,61M | Net Income (TTM) | 30,42M |
| ROE | 8,67% | ROA | 8,88% |
| Gross Margin | 99,96% | Operating Margin | 34,07% |
| Net Margin | 47,09% | Free Cash Flow (TTM) | 125,34M |
| ROIC | 4,88% | FCF Growth (3Y) | -17,66% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 76,60 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 34,22 | P/B Ratio | 3,08 |
| P/S Ratio | 16,11 | PEG Ratio | -1,05 |
| EV/EBITDA | 47,09 | Dividend Yield | 0,00% |
| Market Cap | 1,04B | Enterprise Value | 1,04B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 64,61M | 216,83M | 231,93M | 14,55M | 3,20M |
| Net Income | 30,42M | 142,04M | 157,08M | 184 000,0 | -7,79M |
| EPS (Diluted) | 0,24 | 1,09 | 1,20 | 0,00 | -0,07 |
| Gross Profit | 64,59M | 183,86M | 205,17M | 14,54M | 3,19M |
| Operating Income | 22,02M | 146,19M | 172,49M | -1,60M | -17,75M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 342,72M | 409,71M | 247,97M | 43,27M | 40,06M |
| Total Liabilities | 4,40M | 45,80M | 42,76M | 1,68M | 803 000,0 |
| Shareholders' Equity | 338,32M | 363,90M | 205,21M | 41,59M | 39,25M |
| Total Debt | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Cash & Equivalents | 4,23M | 3,15M | 17,09M | 40,18M | 36,78M |
| Current Assets | 332,10M | 399,33M | 247,16M | 43,25M | 40,04M |
| Current Liabilities | 4,34M | 45,76M | 42,76M | 1,68M | 803 000,0 |